Literature DB >> 29617661

Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.

Zhongqi Ge1, Jake S Leighton2, Yumeng Wang3, Xinxin Peng1, Zhongyuan Chen4, Hu Chen3, Yutong Sun5, Fan Yao6, Jun Li1, Huiwen Zhang7, Jianfang Liu8, Craig D Shriver9, Hai Hu8, Helen Piwnica-Worms6, Li Ma6, Han Liang10.   

Abstract

Protein ubiquitination is a dynamic and reversible process of adding single ubiquitin molecules or various ubiquitin chains to target proteins. Here, using multidimensional omic data of 9,125 tumor samples across 33 cancer types from The Cancer Genome Atlas, we perform comprehensive molecular characterization of 929 ubiquitin-related genes and 95 deubiquitinase genes. Among them, we systematically identify top somatic driver candidates, including mutated FBXW7 with cancer-type-specific patterns and amplified MDM2 showing a mutually exclusive pattern with BRAF mutations. Ubiquitin pathway genes tend to be upregulated in cancer mediated by diverse mechanisms. By integrating pan-cancer multiomic data, we identify a group of tumor samples that exhibit worse prognosis. These samples are consistently associated with the upregulation of cell-cycle and DNA repair pathways, characterized by mutated TP53, MYC/TERT amplification, and APC/PTEN deletion. Our analysis highlights the importance of the ubiquitin pathway in cancer development and lays a foundation for developing relevant therapeutic strategies.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FBXW7; The Cancer Genome Atlas; biomarker; cancer prognosis; pan-cancer analysis; therapeutic targets; tumor subtype; ubiquitin pathway

Mesh:

Substances:

Year:  2018        PMID: 29617661      PMCID: PMC5916807          DOI: 10.1016/j.celrep.2018.03.047

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.995


  58 in total

1.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

Review 2.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling.

Authors:  Stephen J Wicks; Katherine Haros; Marjorie Maillard; Ling Song; Robert E Cohen; Peter Ten Dijke; Andrew Chantry
Journal:  Oncogene       Date:  2005-12-01       Impact factor: 9.867

5.  Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

Authors:  Katherine A Hoadley; Christina Yau; Denise M Wolf; Andrew D Cherniack; David Tamborero; Sam Ng; Max D M Leiserson; Beifang Niu; Michael D McLellan; Vladislav Uzunangelov; Jiashan Zhang; Cyriac Kandoth; Rehan Akbani; Hui Shen; Larsson Omberg; Andy Chu; Adam A Margolin; Laura J Van't Veer; Nuria Lopez-Bigas; Peter W Laird; Benjamin J Raphael; Li Ding; A Gordon Robertson; Lauren A Byers; Gordon B Mills; John N Weinstein; Carter Van Waes; Zhong Chen; Eric A Collisson; Christopher C Benz; Charles M Perou; Joshua M Stuart
Journal:  Cell       Date:  2014-08-07       Impact factor: 41.582

6.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

Review 7.  When ubiquitin meets ubiquitin receptors: a signalling connection.

Authors:  Pier Paolo Di Fiore; Simona Polo; Kay Hofmann
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

8.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.

Authors:  Craig H Mermel; Steven E Schumacher; Barbara Hill; Matthew L Meyerson; Rameen Beroukhim; Gad Getz
Journal:  Genome Biol       Date:  2011-04-28       Impact factor: 13.583

9.  UUCD: a family-based database of ubiquitin and ubiquitin-like conjugation.

Authors:  Tianshun Gao; Zexian Liu; Yongbo Wang; Han Cheng; Qing Yang; Anyuan Guo; Jian Ren; Yu Xue
Journal:  Nucleic Acids Res       Date:  2012-11-20       Impact factor: 16.971

Review 10.  Drugging the undruggables: exploring the ubiquitin system for drug development.

Authors:  Xiaodong Huang; Vishva M Dixit
Journal:  Cell Res       Date:  2016-03-22       Impact factor: 25.617

View more
  42 in total

Review 1.  Identifying Epistasis in Cancer Genomes: A Delicate Affair.

Authors:  Joris van de Haar; Sander Canisius; Michael K Yu; Emile E Voest; Lodewyk F A Wessels; Trey Ideker
Journal:  Cell       Date:  2019-05-30       Impact factor: 41.582

Review 2.  Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Authors:  Joseph A Caruso; Mylinh T Duong; Jason P W Carey; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2018-09-07       Impact factor: 12.701

3.  An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases.

Authors:  Di Chen; Zhen Ning; Huan Chen; Chang Lu; Xiaolong Liu; Tian Xia; Huan Qi; Wen Wang; Ting Ling; Xin Guo; Dinesh Singh Tekcham; Xiumei Liu; Jing Liu; Aman Wang; Qiu Yan; Ji-Wei Liu; Guang Tan; Hai-Long Piao
Journal:  Oncogene       Date:  2019-09-11       Impact factor: 9.867

4.  CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis.

Authors:  Jiaqi Shi; Xin Guan; Fei Zhan; Chao Liu; Zhiwei Li; Yuanfei Yao; Bojun Wang; Changjie Lou; Yanqiao Zhang
Journal:  Cancer Biol Ther       Date:  2019-07-16       Impact factor: 4.742

5.  Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer.

Authors:  Francisco Martínez-Jiménez; Ferran Muiños; Erika López-Arribillaga; Nuria Lopez-Bigas; Abel Gonzalez-Perez
Journal:  Nat Cancer       Date:  2019-12-02

6.  Comprehensive characterization of the rRNA metabolism-related genes in human cancer.

Authors:  Kaisa Cui; Cheng Liu; Xu Li; Qiang Zhang; Youjun Li
Journal:  Oncogene       Date:  2019-09-23       Impact factor: 9.867

7.  Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination.

Authors:  M Steklov; S Pandolfi; M F Baietti; A Batiuk; P Carai; P Najm; M Zhang; H Jang; F Renzi; Y Cai; L Abbasi Asbagh; T Pastor; M De Troyer; M Simicek; E Radaelli; H Brems; E Legius; J Tavernier; K Gevaert; F Impens; L Messiaen; R Nussinov; S Heymans; S Eyckerman; A A Sablina
Journal:  Science       Date:  2018-11-15       Impact factor: 47.728

8.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

9.  Revealing the impact of structural variants in multiple myeloma.

Authors:  Ola Landgren; Francesco Maura; Even H Rustad; Venkata D Yellapantula; Dominik Glodzik; Kylee H Maclachlan; Benjamin Diamond; Eileen M Boyle; Cody Ashby; Patrick Blaney; Gunes Gundem; Malin Hultcrantz; Daniel Leongamornlert; Nicos Angelopoulos; Luca Agnelli; Daniel Auclair; Yanming Zhang; Ahmet Dogan; Niccolò Bolli; Elli Papaemmanuil; Kenneth C Anderson; Philippe Moreau; Hervé Avet-Loiseau; Nikhil C Munshi; Jonathan J Keats; Peter J Campbell; Gareth J Morgan
Journal:  Blood Cancer Discov       Date:  2020-09-15

10.  The deubiquitinase JOSD2 is a positive regulator of glucose metabolism.

Authors:  Lyudmila Krassikova; Boxi Zhang; Divya Nagarajan; André Lima Queiroz; Merve Kacal; Evangelos Samakidis; Helin Vakifahmetoglu-Norberg; Erik Norberg
Journal:  Cell Death Differ       Date:  2020-10-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.